Delivering Value To Those We Serve

Overview

Recent News

Date Title and Summary
Toggle Summary DepoMed, Inc. Announces Initial Public Offering
FOSTER CITY, CA - November 5, 1997 -- DepoMed, Inc. today announced its initial public offering of 1,200,000 Units (each Unit consisting of one share of common stock and one common stock purchase warrant), at a price of $6.10 per Unit. The Units are quoted on the Nasdaq Small Cap Market under the
Toggle Summary DepoMed, Inc. Announces Separation of Units
FOSTER CITY, CA - December 1, 1997 - DepoMed, Inc. (Nasdaq: DPMDU) today announced that, effective December 1, 1997, the Common Stock and Warrants comprising the Company's Units will become detachable and separately transferable. Also effective as of December 1, 1997, the shares of Common Stock and
Toggle Summary DR. W. Leigh Thompson Joins Depomed's Board
FOSTER CITY, CA - February 12, 1998 - DepoMed, Inc. today announced that Dr. W. Leigh Thompson was elected to the Board of Directors on January 30, 1998. Dr. Thompson (59) was previously Chief Scientific Officer at Eli Lilly before founding Profound Quality Resources, Ltd., a private healthcare

Upcoming Events

There are currently no events to display.

Recent SEC Filings

Filing date Description Form Filing Group View

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com
 

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA
 

Investor Relations Contact

John B. Thomas
SVP, Investor Relations & Corporate Communications
jthomas@assertiotx.com